United Kingdom Diabetes Care Devices Market Outlook to 2018 - Glucose Monitoring and Insulin Delivery

NEW YORK, Oct. 16, 2012 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

 

United Kingdom Diabetes Care Devices Market Outlook to 2018 - Glucose Monitoring and Insulin Delivery

http://www.reportlinker.com/p0739473/United-Kingdom-Diabetes-Care-Devices-Market-Outlook-to-2018---Glucose-Monitoring-and-Insulin-Delivery.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Pathology

 

United Kingdom Diabetes Care Devices Market Outlook to 2018 - Glucose Monitoring and Insulin Delivery

 

Summary

 

GlobalData's new report, "United Kingdom Diabetes Care Devices Market Outlook to 2018- Glucose Monitoring and Insulin Delivery" provides key market data on the United Kingdom Diabetes Care Devices market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within two market categories – Glucose Monitoring and Insulin Delivery. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on company financials and pipeline products, wherever available.

 

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

 

Scope

 

- Market size and company share data for Diabetes Care Devices market categories – Glucose Monitoring and Insulin Delivery.

- Annualized market revenues (USD million), volume (units) and average price (USD) data for each of the segments and sub-segments within two market categories. Data from 2004 to 2011, forecast forward for 7 years to 2018.

- 2011 company shares and distribution shares data for each of the two market categories.

- Global corporate-level profiles of key companies operating within the United Kingdom Diabetes Care Devices market.

- Key players covered include F. Hoffmann-La Roche Ltd., Novo Nordisk A/S, Sanofi, Eli Lilly and Company, LifeScan, Inc., Becton, Dickinson and Company and others.

 

Reasons to buy

 

- Develop business strategies by identifying the key market categories and segments poised for strong growth.

- Develop market-entry and market expansion strategies.

- Design competition strategies by identifying who-stands-where in the United Kingdom Diabetes Care Devices competitive landscape.

- Develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future.

- What are the key distribution channels and what's the most preferred mode of product distribution – Identify, understand and capitalize.

 

 

 

1 Table of Contents

1 Table of Contents 2

1.1 List of Tables 6

1.2 List of Figures 7

2 Introduction 9

2.1 What is This Report About? 9

3 Diabetes Care Devices In United Kingdom 10

3.1 Diabetes Care Devices, Market Segmentation 10

3.2 Diabetes Care Devices, United Kingdom, Overall Revenue ($m), USD Constant, 2004-2018 11

3.3 Diabetes Care Devices Market, United Kingdom, Revenue Mix ($m), 2011 12

3.4 Diabetes Care Devices Market, United Kingdom, Category Contribution (%), 2011 13

3.5 Diabetes Care Devices, United Kingdom, Company Share (2010-2011) 20

4 Glucose Monitoring In United Kingdom 22

4.1 Glucose Monitoring, Market Segmentation 22

4.2 Glucose Monitoring Market, United Kingdom, Revenue Mix ($m), 2011 23

4.3 Glucose Monitoring Market, United Kingdom, Segment Contribution (%), 2011 24

4.4 Glucose Monitoring Overall Revenue, (2004-2018) 25

4.4.1 Blood Glucose Meters, Revenue (2004-2018) 29

4.5 Glucose Monitoring Overall Volume (2004-2018) 33

4.5.1 Blood Glucose Meters, Volume (2004-2018) 37

4.6 Glucose Monitoring Average Price (2004-2018) 41

4.7 Glucose Monitoring Distribution Share (2010-2011) 42

4.8 Glucose Monitoring, United Kingdom, Company Share (2010-2011) 43

5 Insulin Delivery In United Kingdom 45

5.1 Insulin Delivery, Market Segmentation 45

5.2 Insulin Delivery Market, United Kingdom, Revenue Mix ($m), 2011 46

5.3 Insulin Delivery Market, United Kingdom, Segment Contribution (%), 2011 47

5.4 Insulin Delivery Overall Revenue, (2004-2018) 48

5.4.1 Insulin Pens, Revenue (2004-2018) 52

5.4.2 Insulin Pumps, Revenue (2004-2018) 56

5.5 Insulin Delivery Overall Volume (2004-2018) 60

5.5.1 Insulin Pens, Volume (2004-2018) 64

5.5.2 Insulin Pumps, Volume (2004-2018) 68

5.6 Insulin Delivery Average Price (2004-2018) 72

5.7 Insulin Delivery Distribution Share (2010-2011) 74

5.8 Insulin Delivery, United Kingdom, Company Share (2010-2011) 75

6 Overview of Key Companies in United Kingdom Diabetes Care Devices Market 77

6.1 F. Hoffmann-La Roche Ltd. 77

6.1.1 Company Overview 77

6.1.2 Share in the United Kingdom Diabetes Care Devices Market 77

6.2 Novo Nordisk A/S 78

6.2.1 Company Overview 78

6.2.2 Share in the United Kingdom Diabetes Care Devices Market 78

6.3 Sanofi 79

6.3.1 Company Overview 79

6.3.2 Share in the United Kingdom Diabetes Care Devices Market 79

6.4 Eli Lilly and Company 80

6.4.1 Company Overview 80

6.4.2 Share in the United Kingdom Diabetes Care Devices Market 80

6.5 LifeScan, Inc. 81

6.5.1 Company Overview 81

6.5.2 Share in the United Kingdom Diabetes Care Devices Market 81

6.6 Becton, Dickinson and Company 82

6.6.1 Company Overview 82

6.6.2 Share in the United Kingdom Diabetes Care Devices Market 82

6.7 Bayer HealthCare AG 83

6.7.1 Company Overview 83

6.8 Abbott Laboratories 83

6.8.1 Company Overview 83

6.9 Medtronic, Inc. 84

6.9.1 Company Overview 84

6.10 Animas Corporation 84

6.10.1 Company Overview 84

6.11 Ypsomed Holding AG 85

6.11.1 Company Overview 85

6.12 Home Diagnostics (UK) Limited 85

6.12.1 Company Overview 85

6.13 ARKRAY, Inc. 85

6.13.1 Company Overview 85

6.14 B. Braun Melsungen AG 86

6.14.1 Company Overview 86

7 Diabetes Care Devices Market Pipeline Products 87

8 Financial Deals Landscape 91

8.1 Partnerships 91

8.1.1 Insulet Expands Distribution Agreement With Ypsomed Holding 91

8.1.2 Mendor Enters Into Distribution Agreement With Merck Serono 92

9 Recent Developments 93

9.1 Research And Development 93

9.1.1 Apr 04, 2012: Takeda Joins Structural Genomics Consortium To Fund Collective Drug Research 93

9.2 Product News 94

9.2.1 Mar 19, 2009: Accu-Chek Inform II Blood Glucose Monitoring System Helps To Improve Patient Care 94

10 Appendix 95

10.1 Definitions of Markets Covered in the Report 96

10.1.1 Diabetes Care Devices 96

10.2 Research Methodology 98

10.3 Secondary Research 98

10.4 Primary Research 99

10.5 Models 99

10.6 Forecasts 100

10.7 Expert Panels 100

10.8 GlobalData Consulting 100

10.9 Currency Conversion 100

10.10 Contact Us 101

10.11 Disclaimer 101

 

1.1 List of Tables

 

Table 1: Diabetes Care Devices, United Kingdom, Overall Revenue ($m), USD Constant, 2004-2018 11

Table 2: Diabetes Care Devices Market, United Kingdom, Category Contribution (%), 2011 13

Table 3: Diabetes Care Devices, United Kingdom, Cross-Segment Analysis, 2004-2018 15

Table 4: Diabetes Care Devices, United Kingdom, Overall Revenue ($m), USD Constant, Historic, 2004-2011 17

Table 5: Diabetes Care Devices, United Kingdom, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 19

Table 6: Diabetes Care Devices, United Kingdom, Company Share by Revenue ($m), USD Constant, 2010-2011 21

Table 7: Glucose Monitoring Market, United Kingdom, Segment Contribution (%), 2011 24

Table 8: Glucose Monitoring, United Kingdom, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011 26

Table 9: Glucose Monitoring, United Kingdom, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018 28

Table 10: Blood Glucose Meters, United Kingdom, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 30

Table 11: Blood Glucose Meters, United Kingdom, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 32

Table 12: Glucose Monitoring, United Kingdom, Volume (Units) by Segment, Historic, 2004-2011 34

Table 13: Glucose Monitoring, United Kingdom, Volume (Units) by Segment, Forecast, 2011-2018 36

Table 14: Blood Glucose Meters, United Kingdom, Volume (Units) by Sub-Segment, Historic, 2004-2011 38

Table 15: Blood Glucose Meters, United Kingdom, Volume (Units) by Sub-Segment, Forecast, 2011-2018 40

Table 16: Glucose Monitoring, United Kingdom, Average Price ($), Historic, 2004-2011 41

Table 17: Glucose Monitoring, United Kingdom, Average Price ($), Forecast, 2011-2018 41

Table 18: Glucose Monitoring, United Kingdom, Distribution Share by Revenue ($m), USD Constant, 2010-2011 42

Table 19: Glucose Monitoring, United Kingdom, Company Share by Revenue ($m), USD Constant, 2010-2011 44

Table 20: Insulin Delivery Market, United Kingdom, Segment Contribution (%), 2011 47

Table 21: Insulin Delivery, United Kingdom, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011 49

Table 22: Insulin Delivery, United Kingdom, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018 51

Table 23: Insulin Pens, United Kingdom, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 53

Table 24: Insulin Pens, United Kingdom, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 55

Table 25: Insulin Pumps, United Kingdom, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 57

Table 26: Insulin Pumps, United Kingdom, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 59

Table 27: Insulin Delivery, United Kingdom, Volume (Units) by Segment, Historic, 2004-2011 61

Table 28: Insulin Delivery, United Kingdom, Volume (Units) by Segment, Forecast, 2011-2018 63

Table 29: Insulin Pens, United Kingdom, Volume (Units) by Sub-Segment, Historic, 2004-2011 65

Table 30: Insulin Pens, United Kingdom, Volume (Units) by Sub-Segment, Forecast, 2011-2018 67

Table 31: Insulin Pumps, United Kingdom, Volume (Units) by Sub-Segment, Historic, 2004-2011 69

Table 32: Insulin Pumps, United Kingdom, Volume (Units) by Sub-Segment, Forecast, 2011-2018 71

Table 33: Insulin Delivery, United Kingdom, Average Price ($), Historic, 2004-2011 72

Table 34: Insulin Delivery, United Kingdom, Average Price ($), Forecast, 2011-2018 73

Table 35: Insulin Delivery, United Kingdom, Distribution Share by Revenue ($m), USD Constant, 2010-2011 74

Table 36: Insulin Delivery, United Kingdom, Company Share by Revenue ($m), USD Constant, 2010-2011 76

Table 37: Diabetes Care Devices Market Pipeline Products 87

Table 38: Insulet Expands Distribution Agreement With Ypsomed Holding 91

Table 39: Mendor Enters Into Distribution Agreement With Merck Serono 92

 

1.2 List of Figures

 

Figure 1: Diabetes Care Devices, Market Segmentation 10

Figure 2: Diabetes Care Devices, United Kingdom, Overall Revenue ($m), USD Constant, 2004-2018 11

Figure 3: Diabetes Care Devices Market, United Kingdom, Revenue Mix ($m), 2011 12

Figure 4: Diabetes Care Devices Market, United Kingdom, Category Contribution (%), 2011 13

Figure 5: Diabetes Care Devices, United Kingdom, Cross-Segment Analysis, 2004-2018 14

Figure 6: Diabetes Care Devices, United Kingdom, Overall Revenue ($m), USD Constant, Historic, 2004-2011 16

Figure 7: Diabetes Care Devices, United Kingdom, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 18

Figure 8: Diabetes Care Devices, United Kingdom, Company Share (%), 2011 20

Figure 9: Glucose Monitoring, Market Segmentation 22

Figure 10: Glucose Monitoring Market, United Kingdom, Revenue Mix ($m), 2011 23

Figure 11: Glucose Monitoring Market, United Kingdom, Segment Contribution (%), 2011 24

Figure 12: Glucose Monitoring, United Kingdom, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011 25

Figure 13: Glucose Monitoring, United Kingdom, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018 27

Figure 14: Blood Glucose Meters, United Kingdom, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 29

Figure 15: Blood Glucose Meters, United Kingdom, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 31

Figure 16: Glucose Monitoring, United Kingdom, Volume (Units) by Segment, Historic, 2004-2011 33

Figure 17: Glucose Monitoring, United Kingdom, Volume (Units) by Segment, Forecast, 2011-2018 35

Figure 18: Blood Glucose Meters, United Kingdom, Volume (Units) by Sub-Segment, Historic, 2004-2011 37

Figure 19: Blood Glucose Meters, United Kingdom, Volume (Units) by Sub-Segment, Forecast, 2011-2018 39

Figure 20: Glucose Monitoring, United Kingdom, Company Share (%), 2011 43

Figure 21: Insulin Delivery, Market Segmentation 45

Figure 22: Insulin Delivery Market, United Kingdom, Revenue Mix ($m), 2011 46

Figure 23: Insulin Delivery Market, United Kingdom, Segment Contribution (%), 2011 47

Figure 24: Insulin Delivery, United Kingdom, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011 48

Figure 25: Insulin Delivery, United Kingdom, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018 50

Figure 26: Insulin Pens, United Kingdom, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 52

Figure 27: Insulin Pens, United Kingdom, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 54

Figure 28: Insulin Pumps, United Kingdom, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 56

Figure 29: Insulin Pumps, United Kingdom, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 58

Figure 30: Insulin Delivery, United Kingdom, Volume (Units) by Segment, Historic, 2004-2011 60

Figure 31: Insulin Delivery, United Kingdom, Volume (Units) by Segment, Forecast, 2011-2018 62

Figure 32: Insulin Pens, United Kingdom, Volume (Units) by Sub-Segment, Historic, 2004-2011 64

Figure 33: Insulin Pens, United Kingdom, Volume (Units) by Sub-Segment, Forecast, 2011-2018 66

Figure 34: Insulin Pumps, United Kingdom, Volume (Units) by Sub-Segment, Historic, 2004-2011 68

Figure 35: Insulin Pumps, United Kingdom, Volume (Units) by Sub-Segment, Forecast, 2011-2018 70

Figure 36: Insulin Delivery, United Kingdom, Company Share (%), 2011 75

Figure 37: F. Hoffmann-La Roche Ltd., Company Share (%),United Kingdom Diabetes Care Devices Market, 2011 77

Figure 38: Novo Nordisk A/S, Company Share (%),United Kingdom Diabetes Care Devices Market, 2011 78

Figure 39: Sanofi, Company Share (%),United Kingdom Diabetes Care Devices Market, 2011 79

Figure 40: Eli Lilly and Company, Company Share (%),United Kingdom Diabetes Care Devices Market, 2011 80

Figure 41: LifeScan, Inc., Company Share (%),United Kingdom Diabetes Care Devices Market, 2011 81

Figure 42: Becton, Dickinson and Company, Company Share (%),United Kingdom Diabetes Care Devices Market, 2011 82

 

Companies mentioned

F. Hoffmann-La Roche Ltd.

Novo Nordisk A/S

Sanofi

Eli Lilly and Company

LifeScan, Inc.

Becton, Dickinson and Company

Bayer HealthCare AG

Abbott Laboratories

Medtronic, Inc.

Animas Corporation

Ypsomed Holding AG

Home Diagnostics (UK) Limited

ARKRAY,

 

 

 

To order this report:

Pathology Industry: United Kingdom Diabetes Care Devices Market Outlook to 2018 - Glucose Monitoring and Insulin Delivery

 

Nicolas Bombourg
Reportlinker
Email: nicolasbombourg@reportlinker.com
US: (805)652-2626
Intl: +1 805-652-2626

 

SOURCE Reportlinker



RELATED LINKS
http://www.reportlinker.com

More by this Source


Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

 

PR Newswire Membership

Fill out a PR Newswire membership form or contact us at (888) 776-0942.

Learn about PR Newswire services

Request more information about PR Newswire products and services or call us at (888) 776-0942.